Meet our leaders #8
Dr. ANNET HEUVELINK WG2 vice leader Senior Scientist Microbiology, R&D, Royal GD, Deventer, the Netherlands “Like bacteria cross borders, we have to cross borders, to both harmonize laboratory methods and treatment guidelines, and equally important, to i...
Read More
ENOVAT is supporting and promoting two special issues in the Antibiotics journal
ENOVAT is supporting and promoting the submission of ENOVAT-related research findings in these two special issues where some of our members are editors: Special Issue “Optimization of Veterinary Antimicrobial Treatment in Companion and Food Animals...
Read More
Meet our leaders #7
Ms Chantal BRITT Working Group 5 Leader Communications Officer at Swiss 3R Competence Centre, Switzerland “A dedicated one health approach and an effective communication strategy to disseminate relevant information to all stakeholders are key to impacting ve...
Read More
Working groups update: December 2020
Recent activities and progress of the different WGs in ENOVAT: Overview of ongoing work (Feb 2020 – Nov 2020) Working Group 1 Since the last Working Groups meeting in February in Albania, WG1 has been undertaking a wealth of work towards achieving its m...
Read More
Meet our leaders #6
Dr Lisbeth Rem JESSEN WG4 leader Associate Professor at University of Copenhagen, Denmark “The prescribers of antimicrobials are key figures in the fight against antimicrobial resistance. We strive to create rational antimicrobial use guidelines that are mea...
Read More
Meet our leaders #5
Prof Petra Picò CAGNARDI WG3 leader Associate Professor, University of Milan, Italy “The integration of pharmacokinetic and pharmacodynamic data is crucial to define veterinary clinical breakpoints for optimization of antimicrobial treatment and limitation ...
Read More